Opinions

Paul Thornton Trillium Therapeutics Inc TRIL-T HOLD Nov 13, 2009

(Market Call Minute.) Volatile stock and you can hold it if it hangs in there but be careful.

Paul Thornton

Unknown

Unlock Rating

$0.155

Stock price when the opinion was issued

Consumer Products

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

WATCH

Fascinated by the technology, they’re taking 2 off patent drugs and combining them to use in therapy for stroke victims. Has a lot of potential. Still has some huge upside.

COMMENT

Pfizer bought it today, and TRIL shares tripled from $6 to $18 in the blink of an eye. That's why he always advises investing in small drug companies; sometimes they pan out.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Paul Thornton Trillium Therapeutics Inc TRIL-T HOLD Nov 13, 2009

You might be interested:

Trillium Therapeutics Inc(TRIL-T)

Trillium Therapeutics Inc(TRIL-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Brendan Caldwell

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase Insights

Jim Cramer - Mad Money

Rebecca Teltscher